Etripamil Nasal Spray Under Review for Managing PSVT Episodes

The FDA has accepted for review the New Drug Application for etripamil nasal spray for the management of paroxysmal supraventricular tachycardia.

Related Keywords

,Milestone Pharmaceuticals ,Drug Administration ,New Drug Application ,